Curebase Raises $15M in Series A Funding
- Curebase, a San Francisco, CA-based provider of decentralized clinical research software and services, raised $15M in Series A funding
- The round, which brings the total raised to $19M, was led by GGV Capital
- In conjunction with the funding, Jeff Richards, managing partner, GGV Capital, will join companies board of directors
- The company intends to use the funds for platform development, expansion of its market presence and consolidation of the technology
- The platform enables any patient and any healthcare provider to be part of a clinical study, accelerating enrollment and enabling novel study designs with diverse populations
- The company operates as a complete eClinical software platform and virtual research site with features
